Pneumococcal polysaccharide vaccination of healthcare workers during an influenza pandemic is cost-effective from a societal perspective but not from a hospital perspective without external subsidy.

Please provide your email address to receive an email when new articles are posted on . To avoid uncertainty, an expert recommends physicians understand each vaccine’s serotypes and which ones are ...

Human antibodies to bacterial polyaaccharides consist primarily of IgG and are largely restricted to the IgG2 subclass. We examined the ontogeny of the IgG subclass response to pneumococcal ...

Please provide your email address to receive an email when new articles are posted on . The winter holidays bring generations of families together. The season also brings a heightened risk for ...

BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China National Medical ...

Improving influenza and pneumococcal vaccination rates through outpatient standing order programs, which allow vaccination without physician orders, is economically favorable in older Americans. A ...

(RTTNews) - Sinovac Biotech Ltd. (SVA), a China-based biopharmaceutical company, said Wednesday that the China National Medical Products Administration or NMPA has approved and issued a product ...